New cancer pill enters first human trials
Disease control
Recruiting now
This is the first study in humans of an experimental tablet called SWA1211 for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, understand how the body processes the drug, and look for early signs that it mi…
Phase: PHASE1 • Sponsor: Beijing StoneWise Technology Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC